G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/28/2002	WO2001073434A3 Identification of nuclear receptor-dependent coregulator recruitment
11/28/2002	WO2001073108A3 A bacterial two-hybrid system for protein interaction screening
11/28/2002	WO2001068911A3 Diagnosis of diseases associated with the cell cycle
11/28/2002	WO2001059459A3 Compositions and methods for screening therapeutic agents
11/28/2002	WO2001042473A9 Device and method for accelerated hydration of dry chemical sensors
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	WO2001017958A9 Neuropeptide sf receptor assays, compounds and therapeutic methods
11/28/2002	WO2001016378A9 Chromosome-wide analysis of protein-dna interactions
11/28/2002	WO2000072004A3 Method of determining the three-dimensional shape of a macromolecule
11/28/2002	US20020178458 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177987 Spatial profiling of proteins using hydrophobic moments
11/28/2002	US20020177958 System, method and computer implemented process for assaying coagulation in fluid samples
11/28/2002	US20020177956 Apparatus for the automation of chemical reaction kinetics studies
11/28/2002	US20020177788 Method and device for sampling and analyzing interstitial fluid and whole blood samples
11/28/2002	US20020177778 Method of detecting amyloid-containing lesions by autofluorescence
11/28/2002	US20020177764 Monitoring analyte concentration using minimally invasive devices
11/28/2002	US20020177696 Compositions and methods relating to breast specific genes and proteins
11/28/2002	US20020177692 Protein complex for use in the diagnosis, prevention and treatment of cell proliferative disorders
11/28/2002	US20020177689 Compounds for the treatment of sexual dysfunction
11/28/2002	US20020177614 Preventing neural tissue damage caused by adenosine-diphosphate- ribosylation of eucaryotic elongation factor-2 (EF-2)
11/28/2002	US20020177553 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177552 Colon tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions; alternatively, antigen presenting cell that expresses a colon tumor protein, or a T cell that is specific for cells expressing such a
11/28/2002	US20020177543 Method for determining the activity of uncoupling proteins (UCPs) by monitoring NAD(P)H consumption
11/28/2002	US20020177527 Methods for the identification of inhibitors of 2'-hydroxyisoflavone reductase expression or activity in plants
11/28/2002	US20020177242 Retentate chromatography and protein chip arrays with applications in biology and medicine
11/28/2002	US20020177241 Determination of the presence and concentration of particle in sample; obtain samle, incubate with label, detect and measure signal from label
11/28/2002	US20020177240 Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
11/28/2002	US20020177235 Measurement of luminescence emitted from sample; obtain sample, incubate with tracer, induce luminescent emission, measure luminescence, compare to control
11/28/2002	US20020177234 Bio-device, and quantitative measurement apparatus and method using the same
11/28/2002	US20020177232 Method and apparatus for detecting illicit substances
11/28/2002	US20020177221 Cellular screening substratum and manufacturing process for it, and method and apparatus for cellular screening with it
11/28/2002	US20020177218 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
11/28/2002	US20020177209 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/28/2002	US20020177194 Polypeptide for use in the treatment of immunological, allergies and autoimmune diseases
11/28/2002	US20020177187 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
11/28/2002	US20020177184 Apparatus for use in the generation of slides of human tissues
11/28/2002	US20020177183 Fixation of preferential tissues; obtain tissue, suspend in circulating fluid stream, expose to microwave radiation, evaluate fixed tissues
11/28/2002	US20020177179 Fluorescent capture assay for kinase activity
11/28/2002	US20020177178 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/28/2002	US20020177177 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays
11/28/2002	US20020177176 Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions
11/28/2002	US20020177175 Biosensor for use in the detection of preferential activities in cells
11/28/2002	US20020177174 High throughput assay for use in the detection preferetial particles in sample; obtain sample, screen for preferential particle, incubate with modulator, detect adjustments in sample structure
11/28/2002	US20020177172 Restoring platelet aggregation in the blood of mammals; obtain sample containing membrane protein, incubate with modulator, monitor aggregation in cells
11/28/2002	US20020177171 Method and means for caries prevention and susceptibility detection
11/28/2002	US20020177168 Detector for use in the detection of preferential chemical intermediates in sample
11/28/2002	US20020177167 Detection of preferential particle in sample; obtain sample, crystalize, analyze, compare to control, detect polymorphs
11/28/2002	US20020177165 Secreted and transmembrane polypeptides and nucleic acids encoding
11/28/2002	US20020177164 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/28/2002	US20020177161 Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy
11/28/2002	US20020177156 Detcting preferential particles in biological fluid; obtain fluid sample, incubate with labelled probe, detect signal from preferential biopolymers
11/28/2002	US20020177149 Detection of marker in cell; obtain cell, monitor image, detect signal, record position of signal
11/28/2002	US20020177147 Mdr1 variants and methods for their use
11/28/2002	US20020177146 Analyzing preferential nucleotide sequences in sample; generate solid support, incubate with nucleotide sequences, measure nucleotide sequences bound to solid support
11/28/2002	US20020177145 Detection and classification of nervous system progenitor cells; obtain tissue, monitor expression of daedalos protein in sample, compare to control, ampified daedalos expression indicates presence of nervous system progenitor cells
11/28/2002	US20020177144 Detection, claassification and measurement of target bioplymers in sample; obtain target biopolymer, bind to solid support, detect and quantify signal from sample,
11/28/2002	US20020177143 Non-alloying core shell nanoparticles
11/28/2002	US20020177137 Detecting preferential nucleotide sequences in pool of sequences; obtain nucleotide sequences, deposit on substrate, incubate with probe, detect signal, which indicates, presencec of preferential sequences
11/28/2002	US20020177131 Identifying a base in a nucleic acid
11/28/2002	US20020177129 Determination of sequence of preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, polymerase and chain termination nucleotide, determine nucleotide sequence
11/28/2002	US20020177128 Variant of LAV viruses
11/28/2002	US20020177127 Compositions and methods for detecting human immunodeficiency virus 2 (HIV-2)
11/28/2002	US20020177125 Polypeptide for use in the treatment of viral disease
11/28/2002	US20020177124 Nucleotide sequences coding polypeptide for use in the detection, prevention and diagnosis viral diseases
11/28/2002	US20020177123 Novel diagnostic screens for type 1 diabetes (IDDM)
11/28/2002	US20020177122 Analyzing and monitoring protein concentration of cells; obtain protein extract, incubate with luminescent dye, separate ad detect adjustments in protein signal
11/28/2002	US20020177121 Three-dimensional ex vivo angiogenesis system
11/28/2002	US20020177120 Assays for apotosis modulators
11/28/2002	US20020176987 Ink comprising: a non-stoichiometric non-equilibrium nanostructured material; device such as electronics using such a material
11/28/2002	US20020176867 Fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues, and the vaccine based on fusion protein, which induces efficient immunological memory
11/28/2002	US20020176865 Genetic engineering
11/28/2002	US20020176864 Two-domain MHC polypeptides include MHC( major histocompatibility complex) class II-based molecules that covalently linked beta 1 and alpha 1 domains, and MHC class I-based molecules that covalently linked alpha-1 and alpha-2
11/28/2002	US20020176857 Culturing stromal cells with bone marrow, quantitative determining the concentration of interleukins by comparing to a standard curve; identifying a patient with a multiple myeloma- related plasmaproliferative disorder
11/28/2002	US20020176821 Each compound composition is tested by contacting it with 10-1000 non-mammalian multi-cellular organisms and determining effect of compound composition on organisms; for screening of libraries of combinatorially produced compounds
11/28/2002	US20020176820 Functional expression of, and assay for, functional cellular receptors in vivo
11/28/2002	US20020176819 Gastrin receptor-avid peptide conjugates
11/28/2002	US20020176806 Application of a disposable tube in biomedical and immunological assays
11/28/2002	US20020176805 For DNA staining and analysis
11/28/2002	US20020176342 Optical disc analysis system including related methods for biological and medical imaging
11/28/2002	US20020176072 Device and method for controlling the quality of microdroplets deposited on a substrate
11/28/2002	US20020176069 System for axial pattern analysis of multicellular organisms
11/28/2002	US20020176068 Apparatus, sample cuvette and method for optical measurements
11/28/2002	US20020175949 System, method, and computer software product for linked window interfaces
11/28/2002	US20020175691 Paving material analyzer system and method
11/28/2002	US20020175087 Electrochemical method for measuring chemical reaction rates
11/28/2002	US20020175086 O2-Sensor fault diagnosis apparatus and method therefor
11/28/2002	US20020174918 Quantitative measuring method and apparatus of metal phase using x-ray diffraction method, and method for making plated steel sheet using them
11/28/2002	US20020174725 Releasing/hooking force meter of the leader pin of the magnetic tape cartridge
11/28/2002	US20020174713 High-temperature characterization of polymer libraries
11/28/2002	US20020174712 Method for determining the viscosity of an operating liquid of an internal combustion engine
11/28/2002	US20020174705 System and method for resetting vehicle engine oil sensors
11/28/2002	DE19940647C2 Verfahren zum Nachweis und zur Quantifizierung von in einer Flüssigkeit befindlichen ersten Biopolymeren A method for the detection and quantification of the first biopolymers contained in a liquid
11/28/2002	DE10216895A1 Moisture measuring method for high humidity has heaters for warming measuring system in region of dew detector
11/28/2002	DE10216658A1 Tester for evaluating the quality of fabric edges, uses the force required to move a test body with a friction surface or claws over a fabric
11/28/2002	DE10125713A1 Preparing immobilized lipid double layers, useful e.g. for investigating membrane proteins, comprises modifying carrier surface to fix orientation of the two layers
11/28/2002	DE10125415A1 Apparatus for the measurement of respiratory gases converts exhaled air into the correct composition of breathing air using a non-dispersive infra red spectroscope
11/28/2002	DE10125188A1 Device for in vivo detection of oxidative stress, comprises determination of thiobarbituric acid-reactive compounds on a solid phase
11/28/2002	DE10125033A1 Use of Sjoegren syndrome antigens as apoptotic targets, useful for diagnosis, treatment, e.g. of cancer or neurodegeneration, and drug screening
11/28/2002	DE10123958A1 Identifying ligands for G protein-coupled receptors, useful for treating cardiovascular disease, by using calcium-sensitive fluorophores in cells expressing G alpha proteins

1 ... 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 ... 3937